Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - Academy


Mostafa Chamekh, Professor (coordinator of the project) - Georges Casimir, Professor - Francis Corazza, Professor- David de Bels, Doctor

ULB - Royal Academy of Medicine of Belgium
" The project aims at understanding why men are more affected than women. Compelling evidences indicate sex-bias in SARS-CoV2 with male representing the majority of severe cases requiring intensive care. Excessive inflammatory symptoms attributed mainly to cytokine storm is the hall-mark of disease progress. We ask whether differences in genetic fitness between male and female patients could contribute to sex-bias and we focus, in particular, on potential role of microRNAs in fine tuning the type and magnitude of the inflammatory response "
Funding: Current application to FNRS IRIS research
Publication References: - Chamekh M, M Deny, M Romano, et al. Differential Susceptibility to Infectious Respiratory Diseases between Males and Females Linked to Sex-Specific Innate Immune Inflammatory Response. Front Immunol. 2017; 8: 1806. - Casimir, G. J., Lefèvre, N., Corazza, F et al. J. Sex and inflammation in respiratory diseases : a clinical...

Nathalie Burnay, Professor

UNamur - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" Vivre le confinement "
Funding: La recherche comporte deux phases successives. La première repose sur un questionnaire tout public comprenant quelques questions fermées et une question ouverte permettant aux répondants d'exprimer leurs ressentis du confinement. Une seconde phase par entretiens semi-directifs est envisagée en fonction des résultats de la phase 1.
Contact: https://www.unamur.be/coronavirus/enquetes https://survey.unamur.be/index.php/462198?lang=fr  
Comment: A ce jour, plus de 400 réponses ont été enregistrées.

O. Vandenberg, Pr. - N. Clumeck, Pr. - C. Montesinos, Pr. - N. Dauby, MD, PhD - C. Gilles, MD - C. Martin, MD - S. Van den Wijngaert, MD - A. Marchant, Pr. - D. Martiny, Pr. - S. De Wit, Pr.

LHUB-ULB - Royal Academy of Medicine of Belgium
" "The purpose of this study is to map the healthcare workers exposure risk in Saint-Pierre University Hospital by combining molecular methods with serological assays. In summary, the short-term objective is threefold: (1) Provide an estimate of the sero-prevalence at baseline among high-risk health care workers (2) Determine prospectively the incidence of new SARS-CoV-2 infections among high-risk health care workers (3) Estimate the healthcare worker exposure to the virus by serological data to help our five partner hospitals in their day-to-day management of the ongoing pandemic The mid-term objectives are: (1) Establish an accurate mapping of the spread of the virus among our population allowing to identify the chain of transmission, (2) Identify predictive immunological markers of susceptibility to infection and disease severity to inform vaccine strategies and, (3) Establish solid diagnosis algorithm that will help adequate lockdown...

Ph. DELVENNE, FNRS Research Director / Chef de service Anatomie pathologique - J. GUIOT, Chef de clinique Pneumologie - L. RENAUD, Chef de service Pneumologie - M. MOUTSCHEN, Chef de service Infectiologie- B. MISSET, Chef de service Soins Intensifs

ULiège, CHU - Royal Academy of Medicine of Belgium
" Nous faisons face à une pandémie d'infection COVID-19. Ce virus pathogène est source de complications pulmonaires aggravant fortement le pronostic de nos patients. De nos jours, tant les mécanismes physiopathologiques en cause que les marqueurs de sévérité de l'atteinte restent indéterminés. Il apparaît donc comme urgent de pouvoir identifier des marqueurs diagnostiques, pronostiques et prédictifs pour nos patients. Dans ce contexte, plusieurs voies rapidement explorables nous apparaissent comme critiques. Le but final de cette étude est de contribuer à une prise en charge plus ciblée des patients porteurs d'une infection au SRAS-Cov-2. "
Funding: Fonds Léon Frederic
Publication References: Dix publications représentatives : 1) Prevention of murine radiogenic thymic lymphomas by tumor necrosis factor or by marrow grafting. HUMBLET C, GREIMERS R, DELVENNE P, DEMAN J, BONIVER J, DEFRESNE MP. J Natl Cancer Inst 88 (1996), 824-831. IF...

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Philippe Denoel, Head of External R&D

GSK - Royal Academy of Medicine of Belgium
" Support covid international: https://www.gsk.com/en-gb/media/resource-centre/our-contribution-to-the-fight-against-2019-ncov/ Support covid en Belgique: https://be.gsk.com/media/915368/cp-gsk-contributions-majeures-de-gsk-a-la-lutte-contre-le-covid-19.pdf NA NA "
Funding: NA
Contact: Philippe Denoel - This email address is being protected from spambots. You need JavaScript enabled to view it.

Philippe PEIGNEUX, Professor - Peter SIMOR, Postdoc IF-ULB - Rebeca SIFUENTES, Aspirant FNRS - Ariadna ALBAJARA SAENZ, postdoctoral researcher

ULB, UR2NF - Neuropsychology and Functional Neuroimaging Research Unit affiliated at CRCN - Center for Research in Cognition and Neurosciences and UNI - ULB Neurosciences Institute - FNRS - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" The aim of the study is to examine day-to-day associations between subjective sleep quality and daytime functioning during the large-scale confinement measures taken in Belgium given the current Covid-19 pandemic in Europe. In particular, we are interested in assessing the interplay between altered patterns of sleep timing, duration and quality, and daytime behaviour, cognition, and affect for 2 weeks during the confinement period. Longitudinal data are obtained in Belgium, Hungary and Spain "
Funding: internal resources
Publication References: ongoing project
Contact: Project : This email address is being protected from spambots. You need JavaScript enabled to view it., Peter Simor: This email address is being protected from spambots. You need JavaScript enabled to view it. Philippe Peigneux : This email address is being protected from spambots. You need JavaScript enabled to view it.

Quentin Papeloer - Naïma Sallem, Dr- Alain Jonas, Professor

UCLouvain - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" 3D printing of protective visors "
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Ruddy Wattiez, Pr. - Lionel Tafforeau, Pr. - Rob Onderwater, Dr. - Stéphanie Roosa, Dr.

UMONS, Materia Nova - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" Development of a test for the antiviral activity of a coating, material or textile. "
Contact: Contact: Pr. Ruddy Wattiez, Vice-rector of research and innovation of the university of Mons This email address is being protected from spambots. You need JavaScript enabled to view it.

Sandy Tubeuf, Professor - Dominique Vanpee, Professor

UCLouvain - Royal Academy of Medicine of Belgium
" TThe project US3R is a general population survey that will measure the magnitude of utilised, postponed and foregone medical care in relation with other health care needs than coronavirus symptoms during the confinement period in Belgium. The study aims to describe the magnitude of unsatisfied health care needs for various types of care. It will also identify the reasons for these postponed and foregone care according to gender, health status, geographical location and socioeconomic status. "
Funding: Budget Jeune Académique UCLouvain (Sandy Tubeuf)
Contact: Sandy Tubeuf, PhD Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Comment: Voir: https://uclouvain.be/fr/decouvrir/presse/actualites/coronavirus-avez-vous-renonce-a-des-soins-medicaux.html Lien vers l'enquête : https://uclouvainph.qualtrics.com/jfe/form/SV_8D3WX8lH34Lf6LP

Souad Rahmouni, Doctor

GIGA-Institute, ULiège - FNRS - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" The main objective of our research program is the identification of human genetic factors impacting the COVID19 pandemic. Within the COVID-19 host genetics initiative (https://www.covid19hg.org/), we will establish a shared set of phenotypes to be combined with genomic data for standard GWAS and further meta-analysis. Field of expertise of our laboratory : genetics, genomics, bioinformatics, immune-response related diseases. In addition, the GIGA Institute is an interdisciplinary research institute from the ULiege devoted to academic excellence in the biomedical sciences to foster ground-breaking medical innovation. It comprises 583 members attached to six faculties (Medicine, Science, Veterinary Medicine, Engineering, Agbiotech, Psychology) that are organized in four disease-based (neuroscience, cancer, infection-inflammation-immunity, cardiovascular) and two method-based thematic units...

Stefan Constantinescu, Professor

UCLouvain - Royal Academy of Medicine of Belgium

Determination of Germ-Line Variations and Pathological Gene Expression that May Contribute to Immunopathology in COVID-19." The SARS-CoV-2 infection (1, 2), can be followed by a severe evolution with severe respiratory distress. We hypothesize that germline variants in genes involved in innate immunity, especially type I interferon induction and actions, predispose to delayed pathological response/cytokine storm. Our aims are to identify: i) such germ-line variants and ii) peripheral leukocyte gene expression that can predict unfavorable SARS-CoV2 infections. A group of SARS-CoV2 patients with unfavorable evolution, young and without co-morbidities (25) will be compared with an aged matched group of 25 SARS-CoV2 individuals with absence or a minimum of symptoms. Germ line DNA obtained from peripheral blood (PB) will be whole exome sequenced (WES) and analyzed with bioinformatics tools that are used for rare disease germline...

Yves BEGUIN, Professor

ULiège - Royal Academy of Medicine of Belgium
" In the context of the COVID-19 pandemic, this project involves collecting samples of human bodily material (HBM) for research projects aimed at better understanding and fighting this disease. 1 / Collection of blood and respiratory HBM from 500 patients with COVID-19 virus infection, as well as of post-mortem kidney and lung biopsies. 2 / Collection of blood HBM from 4000 healthy hospital and university staff members, currently not infected with the SARS-CoV2 virus, but possibly previously infected. SARS-CoV2 serology will be measured at 3 time points during the pandemia. "
Funding: Fondation Léon Frédéricq Wallonia Region ULiège CHU Liège
Contact: Pascale Huynen, Dpt of Microbiology, CHU of Liège. Stéphanie Gofflot, BHUL (CHU of Liège biobank).

Yves Beguin, Professor

Uliège & CHU of Liège - Royal Academy of Medicine of Belgium
" This is a phase 1-2 clinical trial entitled "Mesenchymal stromal cell therapy for severe COVID-19 infection" exploring the safety and preliminary efficacy of treatment with mesenchymal stromal cells in patients with severe COVID-19 infection. "
Funding: CHU of Liège
Contact: Céline Grégoire, Dpt of Hematology M Moutschen, Dpt of Microbiology B Misset, Dpt of Intensive Care C Lechanteur, Lab of Cell Therapy CHU of Liège

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11


Brussels & Wallonia against COVID19